AREV Life Sciences Global Corp. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CAD 0.026483 million compared to CAD 0.048898 million a year ago. Net loss was CAD 0.219914 million compared to CAD 0.158588 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago. For the nine months, sales was CAD 0.113011 million compared to CAD 0.136721 million a year ago. Net loss was CAD 1.49 million compared to CAD 0.546905 million a year ago. Basic loss per share from continuing operations was CAD 0.06 compared to CAD 0.04 a year ago.